Tag Archives: biosimilar


Biosimilars: You Won’t Feel a Thing (For Now, Anyway)

Ogilvy CommonHealth Payer Marketing’s associate account group supervisor, Claire Pisano, discusses how the introduction of biosimilars will shake-up the healthcare landscape. But before the wide adoption of these new products, there are many hurdles to be addressed.

Posted in Access, Branding, clinical trials, Design, Health & Wellness, Healthcare Communications, medical affairs, Pharmaceutical, Pharmacists, Research | Tagged | Comments closed

Apples and Oranges?

Biosimilars: The Sophistication of Generics Biologics—therapeutics derived from living cells—remain complex to produce…and reproduce.  Due to the molecular and structural complexity of large (relatively speaking) biologic proteins, a generic biologic equivalent can only be made “similar,” not identical, to the original, hence the industry term “biosimilar”—this is unlike small-molecule drugs, whose chemical structures can be […]

Posted in Efficacy, Technology | Also tagged , , | Comments closed